Regulon

Regulon: R-1169

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
151.3550410Pr-108Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5164 ENSG00000005882 PDK2 Q15119
1183 ENSG00000073464 CLCN4 P51793
22924 ENSG00000084764 MAPRE3 Q9UPY8
2036 ENSG00000088367 EPB41L1 Q9H4G0
5037 ENSG00000089220 PEBP1 P30086
5595 ENSG00000102882 MAPK3 P27361
57142 ENSG00000115310 RTN4 Q9NQC3
23558 ENSG00000132471 WBP2 A0A024R8L1
9581 ENSG00000138078 PREPL Q4J6C6
23710 ENSG00000139112 GABARAPL1 Q9H0R8
5860 ENSG00000151552 QDPR P09417
8867 ENSG00000159082 SYNJ1 O43426
7259 ENSG00000189241 TSPYL1 Q9H0U9
6844 ENSG00000220205 VAMP2 P63027
80212 ENSG00000275035 CCDC92 F5H7P8

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
TEMUTERKIBMAPK3Small moleculeINHIBITORMitogen-activated protein kinase; ERK1/ERK2 inhibitor20
MK-8353MAPK3Small moleculeINHIBITORMAP kinase ERK1 inhibitor10
ULIXERTINIBMAPK3Small moleculeINHIBITORMAP kinase ERK2 inhibitor20
KO-947MAPK3Small moleculeINHIBITORMitogen-activated protein kinase; ERK1/ERK2 inhibitor10
BOTULINUM TOXIN TYPE BVAMP2UnknownINHIBITORVesicle-associated membrane protein 2 inhibitor40
OZANEZUMABRTN4AntibodyINHIBITORReticulon-4 inhibitor20
RAVOXERTINIBMAPK3Small moleculeINHIBITORMAP kinase ERK2 inhibitor10
ATINUMABRTN4AntibodyINHIBITORReticulon-4 inhibitor10
SODIUM DICHLOROACETATEPDK2Small moleculeINHIBITORPyruvate dehydrogenase kinase inhibitor42

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1169

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs